00:00 Speaker A
We are watching PNC, BYD and Immunity Bio.
00:03 Speaker A
First up is PNC, the regional bank reporting fourth quarter earnings ahead of the opening bell and the stock is jumping.
00:08 Speaker A
Profit topped expectations and earnings were in line with Wall Street estimates.
00:12 Speaker A
Those results driven by increased loan growth and rising demand for its financial services.
00:17 Speaker A
Next up is BYD. Shares jumping in overnight trade on reports the Chinese EV maker is in talks with Ford for a partnership.
00:24 Speaker A
The focus of that those discussions is around batteries.
00:27 Speaker A
Ford would buy them from BYD to use in hybrid vehicles.
00:30 Speaker A
That’s according to the Wall Street Journal.
00:32 Speaker A
The company’s still figuring out the details and it’s also possible a deal would not come to fruition.
00:37 Speaker A
Finally, immunity Bio.
00:39 Speaker A
Now this biotech stock is extending its 2026 rally.
00:42 Speaker A
It has doubled in value already this year, and it’s risen every single trading day in 2026.
00:47 Speaker A
The company’s had several catalysts lifting shares.
00:50 Speaker A
It reported preliminary earnings on Thursday, saying full year revenue from its bladder cancer drug is expected to soar 700% year-over-year.
00:57 Speaker A
Separately this week, the same drug got approval from the Saudi Food and Drug Authority to treat non-small cell lung cancer.